Total treated after 12 months (n=59) | Community GI clinic (n=48) | University liver clinic (n=11) | p Value | |
---|---|---|---|---|
Mean age (years) | 45±12 | 45±12 | 46±15 | 0.84 |
Male | 57.6% | 64.6% | 27.3% | 0.02 |
Asian | 98.3% | 100.0% | 90.9% | 0.04 |
HBeAg-Positive | 28.8% | 31.3% | 18.2% | 0.39 |
Baseline ALT, U/L | 38 (27–52) | 34 (25–46) | 52 (44–54) | 0.01 |
Baseline HBV DNA, log10 IU/mL | 5.2 (4.7–7.1) | 5.3 (4.8–7.4) | 4.8 (4.3–5.8) | 0.14 |
Cirrhosis | 3.4% | 2.1% | 9.1% | 0.25 |
Values are presented as mean±SD, proportions, or median (IQR).
ALT, alanine aminotransferase; HBeAg, hepatitis B e antigen; HBV DNA, hepatitis B virus DNA.